NICE guidance on axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment.
National Institute for Health and Care Excellence, Level 1A City Tower, Piccadilly Plaza, Manchester M1 4BT, UK. Electronic address: nwamaka.umeweni@nice.org.uk.
Nwamaka
N
Umeweni
National Institute for Health and Care Excellence, Level 1A City Tower, Piccadilly Plaza, Manchester M1 4BT, UK.
Boglarka
B
Mikudina
National Institute for Health and Care Excellence, Level 1A City Tower, Piccadilly Plaza, Manchester M1 4BT, UK.
Frances
F
Sutcliffe
National Institute for Health and Care Excellence, Level 1A City Tower, Piccadilly Plaza, Manchester M1 4BT, UK.
Andrew
A
Stevens
D000077784:Axitinib; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D017408:Guidelines as Topic; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D007191:Indazoles / Q000009:adverse effects / Q000627:therapeutic use*
D007093:Imidazoles; D007191:Indazoles; D000077784:Axitinib